The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis

被引:214
作者
Xu, J
Zhong, N
Wang, HY
Elias, JE
Kim, CY
Woldman, I
Pifl, C
Gygi, SP
Geula, C
Yankner, BA
机构
[1] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Dept Neurol, Boston, MA 02135 USA
[2] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[3] Childrens Hosp, Div Neurosci, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[5] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria
[6] Harvard Univ, Sch Med, Dept Med, Dept Med,Lab Neurodgenerat & Aging Res, Boston, MA 02215 USA
[7] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA
关键词
D O I
10.1093/hmg/ddi134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the DJ-1 gene cause early-onset autosomal recessive Parkinson's disease (PD), although the role of DJ-1 in the degeneration of dopaminergic neurons is unresolved. Here we show that the major interacting-proteins with DJ-1 in dopaminergic neuronal cells are the nuclear proteins p54nrb and pyrimidine tract-binding protein-associated splicing factor (PSF), two multifunctional regulators of transcription and RNA metabolism. PD-associated DJ-1 mutants exhibit decreased nuclear distribution and increased mitochondrial localization, resulting in diminished co-localization with co-activator p54nrb and repressor PSF. Unlike pathogenic DJ-1 mutants, wild-type DJ-1 acts to inhibit the transcriptional silencing activity of the PSF. In addition, the transcriptional silencer PSF induces neuronal apoptosis, which can be reversed by wild-type DJ-1 but to a lesser extent by PD-associated DJ-1 mutants. DJ-1-specific small interfering RNA sensitizes cells to PSF-induced apoptosis. Both DJ-1 and p54nrb block oxidative stress and mutant alpha-synuclein-induced cell death. Thus, DJ-1 is a neuroprotective transcriptional co-activator that may act in concert with p54nrb and PSF to regulate the expression of a neuroprotective genetic program. Mutations that impair the transcriptional co-activator function of DJ-1 render dopaminergic heurons vulnerable to apoptosis and may contribute to the pathogenesis of PD.
引用
收藏
页码:1231 / 1241
页数:11
相关论文
共 40 条
[1]   The role of pathogenic DJ-1 mutations in Parkinson's disease [J].
Abou-Sleiman, PM ;
Healy, DG ;
Quinn, N ;
Lees, AJ ;
Wood, NW .
ANNALS OF NEUROLOGY, 2003, 54 (03) :283-286
[2]   Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease [J].
Bonifati, V ;
Oostra, BA ;
Heutink, P .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (03) :163-174
[3]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[4]   The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization [J].
Canet-Avilés, RM ;
Wilson, MA ;
Miller, DW ;
Ahmad, R ;
McLendon, C ;
Bandyopadhyay, S ;
Baptista, MJ ;
Ringe, D ;
Petsko, GA ;
Cookson, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9103-9108
[5]   Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1 [J].
Goldberg, MS ;
Pisani, A ;
Haburcak, M ;
Vortherms, TA ;
Kitada, T ;
Costa, C ;
Tong, Y ;
Martella, G ;
Tscherter, A ;
Martins, A ;
Bernardi, G ;
Roth, BL ;
Pothos, EN ;
Calabresi, P ;
Shen, J .
NEURON, 2005, 45 (04) :489-496
[6]   A NOVEL SET OF SPLICEOSOME-ASSOCIATED PROTEINS AND THE ESSENTIAL SPLICING FACTOR PSF BIND STABLY TO PRE-MESSENGER-RNA PRIOR TO CATALYTIC STEP-II OF THE SPLICING REACTION [J].
GOZANI, O ;
PATTON, JG ;
REED, R .
EMBO JOURNAL, 1994, 13 (14) :3356-3367
[7]   DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease [J].
Hedrich, K ;
Djarmati, A ;
Schäfer, N ;
Hering, R ;
Wellenbrock, C ;
Weiss, PH ;
Hilker, R ;
Vieregge, P ;
Ozelius, LJ ;
Heutink, P ;
Bonifati, V ;
Schwinger, E ;
Lang, AE ;
Noth, J ;
Bressman, SB ;
Pramstaller, PP ;
Riess, O ;
Klein, C .
NEUROLOGY, 2004, 62 (03) :389-394
[8]  
Hedrich K, 2004, ANN NEUROL, V55, P145, DOI 10.1002/ana.10816
[9]  
Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.0.CO
[10]  
2-H